SEC Form 4 · accession 0001209191-16-148482
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kleanthis G Xanthopoulos
Director
Period of report
Nov 2, 2016
Accepted (ET)
Nov 4, 2016 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.575 | Nov 2, 2016 | A | 20,000 | A | — | Nov 2, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The shares underlying the option vest over one year in 12 equal monthly installments, beginning on November 1, 2016.